Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
02 January 2013Website:
http://pharmacyte.comNext earnings report:
11 July 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 76 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is PharmaCyte Biotech?
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
What sector is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Healthcare sector
What industry is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Biotechnology industry
What country is PharmaCyte Biotech from?
PharmaCyte Biotech is headquartered in United States
When did PharmaCyte Biotech go public?
PharmaCyte Biotech initial public offering (IPO) was on 02 January 2013
What is PharmaCyte Biotech website?
https://pharmacyte.com
Is PharmaCyte Biotech in the S&P 500?
No, PharmaCyte Biotech is not included in the S&P 500 index
Is PharmaCyte Biotech in the NASDAQ 100?
No, PharmaCyte Biotech is not included in the NASDAQ 100 index
Is PharmaCyte Biotech in the Dow Jones?
No, PharmaCyte Biotech is not included in the Dow Jones index
When does PharmaCyte Biotech report earnings?
The next expected earnings date for PharmaCyte Biotech is 11 July 2024